{"id":"https://openalex.org/W7203487543","doi":"https://doi.org/10.1158/1078-0432.c.8653836","title":"Data from A Phase 2 Study of the MEK1/2 Inhibitor Luvometinib in Patients with Extracranial Arteriovenous Malformations","display_name":"Data from A Phase 2 Study of the MEK1/2 Inhibitor Luvometinib in Patients with Extracranial Arteriovenous Malformations","publication_year":2026,"publication_date":"2026-08-14","ids":{"openalex":"https://openalex.org/W7203487543","doi":"https://doi.org/10.1158/1078-0432.c.8653836"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.c.8653836","doi":"https://doi.org/10.1158/1078-0432.c.8653836","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.c.8653836","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/1078-0432.c.8653836","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5100752966","display_name":"Chen Hua","orcid":"https://orcid.org/0000-0002-4868-9308","observed_orcids":["https://orcid.org/0000-0002-4868-9308"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Chen Hua","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-4868-9308","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5147183505","display_name":"Zhuli Wu","orcid":"https://orcid.org/0009-0000-8151-502X","observed_orcids":["https://orcid.org/0009-0000-8151-502X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Zhuli Wu","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0000-8151-502X","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5147168817","display_name":"Xingli Wang","orcid":"https://orcid.org/0009-0005-9880-4641","observed_orcids":["https://orcid.org/0009-0005-9880-4641"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Xingli Wang","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0005-9880-4641","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5147222867","display_name":"Huilong Liu","orcid":"https://orcid.org/0009-0000-9001-2010","observed_orcids":["https://orcid.org/0009-0000-9001-2010"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Huilong Liu","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0000-9001-2010","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5136055967","display_name":"Ben Li","orcid":"https://orcid.org/0009-0009-5828-8477","observed_orcids":["https://orcid.org/0009-0009-5828-8477"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ben Li","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0009-5828-8477","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5136035395","display_name":"Yang Zheng","orcid":"https://orcid.org/0009-0008-9300-0486","observed_orcids":["https://orcid.org/0009-0008-9300-0486"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yang Zheng","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0008-9300-0486","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5058827164","display_name":"Xiaoxi Lin","orcid":"https://orcid.org/0000-0002-7325-1367","observed_orcids":["https://orcid.org/0000-0002-7325-1367"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Xiaoxi Lin","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-7325-1367","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10980","display_name":"Vascular Malformations and Hemangiomas","score":0.5493000149726868,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10980","display_name":"Vascular Malformations and Hemangiomas","score":0.5493000149726868,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11402","display_name":"Vascular Malformations Diagnosis and Treatment","score":0.44209998846054077,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12199","display_name":"Vascular Anomalies and Treatments","score":0.002899999963119626,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/mek-inhibitors","display_name":"MEK inhibitors","score":0.9570000171661377},{"id":"https://openalex.org/keywords/extracranial-arteriovenous-malformations","display_name":"extracranial arteriovenous malformations","score":0.9909999966621399},{"id":"https://openalex.org/keywords/targeted-therapy","display_name":"targeted therapy","score":0.8870000243186951},{"id":"https://openalex.org/keywords/lesion-reduction","display_name":"lesion reduction","score":0.3869999945163727},{"id":"https://openalex.org/keywords/treatment-safety","display_name":"treatment safety","score":0.5550000071525574}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9200999736785889},{"id":"https://openalex.org/C2778286760","wikidata":"https://www.wikidata.org/wiki/Q1224954","display_name":"Digital subtraction angiography","level":3,"score":0.7484999895095825},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.6485000252723694},{"id":"https://openalex.org/C2779603958","wikidata":"https://www.wikidata.org/wiki/Q1584110","display_name":"Arteriovenous malformation","level":2,"score":0.6348999738693237},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.6157000064849854},{"id":"https://openalex.org/C126838900","wikidata":"https://www.wikidata.org/wiki/Q77604","display_name":"Radiology","level":1,"score":0.5812000036239624},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.5307000279426575},{"id":"https://openalex.org/C143409427","wikidata":"https://www.wikidata.org/wiki/Q161238","display_name":"Magnetic resonance imaging","level":2,"score":0.5167999863624573},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.4514000117778778},{"id":"https://openalex.org/C2781464078","wikidata":"https://www.wikidata.org/wiki/Q7685898","display_name":"Target lesion","level":4,"score":0.4438999891281128},{"id":"https://openalex.org/C2781156865","wikidata":"https://www.wikidata.org/wiki/Q827023","display_name":"Lesion","level":2,"score":0.4401000142097473},{"id":"https://openalex.org/C146357865","wikidata":"https://www.wikidata.org/wiki/Q1123245","display_name":"Stage (stratigraphy)","level":2,"score":0.4251999855041504},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.39890000224113464},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.38530001044273376},{"id":"https://openalex.org/C2778212899","wikidata":"https://www.wikidata.org/wiki/Q907325","display_name":"Magnetic resonance angiography","level":3,"score":0.3531000018119812},{"id":"https://openalex.org/C2780643987","wikidata":"https://www.wikidata.org/wiki/Q468414","display_name":"Angiography","level":2,"score":0.34850001335144043},{"id":"https://openalex.org/C2778822529","wikidata":"https://www.wikidata.org/wiki/Q1951525","display_name":"Progressive disease","level":3,"score":0.3328000009059906},{"id":"https://openalex.org/C111335779","wikidata":"https://www.wikidata.org/wiki/Q3454686","display_name":"Reduction (mathematics)","level":2,"score":0.32359999418258667},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.289000004529953},{"id":"https://openalex.org/C202953159","wikidata":"https://www.wikidata.org/wiki/Q382695","display_name":"Intention-to-treat analysis","level":3,"score":0.26579999923706055},{"id":"https://openalex.org/C3019096185","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Complete response","level":3,"score":0.26510000228881836},{"id":"https://openalex.org/C2989005","wikidata":"https://www.wikidata.org/wiki/Q214963","display_name":"Nuclear medicine","level":1,"score":0.26420000195503235},{"id":"https://openalex.org/C2777507709","wikidata":"https://www.wikidata.org/wiki/Q121576","display_name":"Vascular malformation","level":2,"score":0.25780001282691956}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1078-0432.c.8653836","doi":"https://doi.org/10.1158/1078-0432.c.8653836","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.c.8653836","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.c.8653836","doi":"https://doi.org/10.1158/1078-0432.c.8653836","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.c.8653836","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7160983020","https://openalex.org/W4410812824","https://openalex.org/W4386885088","https://openalex.org/W4412522776","https://openalex.org/W7161641771","https://openalex.org/W3136032010","https://openalex.org/W2774070406","https://openalex.org/W2921921834","https://openalex.org/W3082152376","https://openalex.org/W2342299903"],"abstract_inverted_index":{"Abstract":[0],"Purpose:":[1],"Extracranial":[2],"arteriovenous":[3],"malformation":[4],"(AVM)":[5],"is":[6],"a":[7,31],"rare":[8],"and":[9,27,53,118,122,171,180,245],"debilitating":[10],"condition":[11],"with":[12,36,62,86,102,235],"significant":[13],"morbidity.":[14],"Clinical":[15],"trial":[16,229],"evidence":[17],"for":[18,43,251],"targeted":[19,231],"therapies":[20],"remains":[21],"limited.":[22],"We":[23,125],"evaluated":[24],"the":[25,226,252],"efficacy":[26,244],"safety":[28],"of":[29,230,254],"luvometinib,":[30],"MEK1/2":[32],"inhibitor,":[33],"in":[34,75,89,105,115,177,187,193,233],"adults":[35,61,234],"complicated":[37],"AVM":[38,134],"that":[39],"were":[40,222],"inoperable,":[41],"unsuitable":[42],"intervention,":[44],"relapsed":[45,65,238],"after":[46],"surgery,":[47],"or":[48,64,196,237],"failed":[49],"previous":[50],"treatment.":[51],"Patients":[52,68],"Methods:":[54],"This":[55],"single-arm":[56],"phase":[57],"2":[58],"study":[59],"enrolled":[60,126],"inoperable":[63,236],"extracranial":[66,239],"AVMs.":[67,255],"received":[69],"luvometinib":[70,241],"8":[71],"mg":[72],"once":[73],"daily":[74],"28-day":[76],"cycles.":[77],"Primary":[78],"endpoint":[79],"was":[80,143,164,191],"objective":[81],"response":[82,157],"rate":[83],"(ORR;":[84],"patients":[85,174,205],"\u226520%":[87,103],"reduction":[88,104,146,159],"lesion":[90,112],"range)":[91],"by":[92,107,141,162],"digital":[93],"subtraction":[94],"angiography":[95],"(DSA).":[96],"Secondary":[97],"endpoints":[98],"included":[99],"ORR":[100,140,161],"(patients":[101],"volume)":[106],"magnetic":[108],"resonance":[109],"imaging":[110],"(MRI),":[111],"clearance,":[113],"improvement":[114],"arterial":[116,178],"flow":[117],"impedance,":[119,181],"clinical":[120,188,228],"symptoms,":[121],"safety.":[123],"Results:":[124],"20":[127],"patients;":[128],"18":[129],"(90%)":[130],"had":[131,175,185,217],"stage":[132],"III":[133],"(median":[135],"follow-up":[136],"duration":[137],"14.6":[138],"months).":[139],"DSA":[142],"64.3%":[144],"[lesion":[145],"\u226520%;":[147],"95%":[148],"confidence":[149],"interval":[150],"(CI),":[151],"35.1\u201387.2];":[152],"35.7%":[153],"achieved":[154,192],"major":[155],"partial":[156],"(lesion":[158],">50%).":[160],"MRI":[163],"61.1%":[165],"(95%":[166],"CI,":[167],"35.7\u201382.7).":[168],"Fourteen":[169],"(77.8%)":[170],"15":[172],"(83.3%)":[173],"improvements":[176,186],"velocity":[179],"respectively;":[182],"12":[183],"(66.7%)":[184],"symptoms.":[189],"Response":[190],"RAS-MARK-mutated,":[194],"EPHB4-mutated,":[195],"mutation-undetected":[197],"patients,":[198],"but":[199],"not":[200],"RASA1-mutated":[201],"patients.":[202],"Nineteen":[203],"(95%)":[204],"experienced":[206],"treatment-emergent":[207],"adverse":[208],"events,":[209],"mostly":[210],"grade":[211,218],"1":[212],"to":[213],"2;":[214],"5":[215],"(25%)":[216],"\u22653.":[219],"No":[220],"deaths":[221],"reported.":[223],"Conclusions:":[224],"In":[225],"first":[227],"therapy":[232],"AVMs,":[240],"demonstrated":[242],"promising":[243],"tolerability,":[246],"supporting":[247],"its":[248],"further":[249],"development":[250],"treatment":[253]},"counts_by_year":[],"updated_date":"2026-11-09T13:22:03.289127","created_date":"2026-08-15T00:00:00"}